@robstp0907.bsky.social💗 Join us for HerHealth Oncology CME Conference 2026
⏳ 16 DAYS TO GO!
📅 Oct 9–10, 2026 | 📍 New York City & Virtual
Earn 10 CME, 10 ABIM MOC & 10 Nursing Contact Hours.
👉 Register: www.emedevents.com/herhealth-on...
#HerHealth2026 #Oncology #CME #Nursing#BreastCancer #GynecologicOncology#Cancer
@cancers-mdpi.bsky.social👏We are proud to welcome 18 new Editorial Board Members to Cancers (August 2026). Wishing our new EBMs huge success in their research and journal contributions! 🌟
🔗Read more: www.mdpi.com/about/announ...
#CancersMDPI #Oncology #Research #OpenAccess
@bcc2026.bsky.socialHave new findings or expertise in breast cancer research?
Interested in speaking at #BreastCancerCongress2027?
Want to present your research?
Zurich, Switzerland| June 17–18,2027
Speaker Request: pinkribboncongress.com/request-spea...
#BreastCancer #Oncology #CancerResearch #MedicalResearch #BCC
@onclive.bsky.socialWATCH 👀: Mary Ann Anderson, MBBS, FRACP, FRCPA, PhD, of @petermaccc.bsky.social, explains how safety, resistance, and sequencing guide frontline therapy selection in CLL.
Full video ➡️: www.onclive.com/view/dr-ande...
#leusm #oncology #SOHO2026 @societyofhemonc.bsky.social
@onclive.bsky.social📰 The @fda.gov has approved and granted competitive generic therapy designation to lanreotide injection, a generic formulation referencing lanreotide, for the treatment of patients with GEP-NETs. #oncology
Full story ➡️: www.onclive.com/view/fda-app...
@aliciaault.bsky.socialOverall cancer incidence decreases for men, slight increase for women, per annual CDC, ACS, NCI report. Good news is that lung cancer incidence and deaths have decreased.
@onclive.bsky.social📰 The TrueBeam photon therapy system has been added to the Statesir Cancer Center at Atlantic Health CentraState Medical Center. #oncology
Read more on our site ➡️: www.onclive.com/view/atlanti...
@onclive.bsky.social📈 The addition of the β-catenin pathway inhibitor tegavivint to osimertinib produced deep responses in a phase 1b study in first-line EGFR-mutated NSCLC. @ascocancer.bsky.social #ASCO26 #lcsm #oncology
More insights ➡️: www.onclive.com/view/tegaviv...
@cureusmedical.bsky.socialA new review of 15 studies found AI-guided chemo selection linked to better survival and response rates, and could spot patients unlikely to benefit from a drug before it's tried. Published in Cureus.
@drtimos.bsky.social🚀 Dive into #ASCOGU25 buzz!
Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.
#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺
Download our full report http://dlvr.it/TVbXz1 !
@onclive.bsky.socialAn observational analysis showed a long-term OS benefit with Orca-T in adult patients undergoing allogeneic transplantation for hematologic malignancies. #hematology #oncology
Learn more ➡️: www.onclive.com/view/orca-t-...
@onclive.bsky.social🔬New research from @danafarber.bsky.social reveals how cancers carrying mutations in the p53 tumor-suppressor protein can hide those mutations from T cells and suggests a therapeutic strategy as a countermeasure. #oncology
Full story ➡️: www.onclive.com/view/making-...
@aiinmeditech.bsky.socialExplore how CAR-T analytics software , pipeline tracking and competitive intelligence can help biopharma teams understand clinical development, competitors and emerging in-vivo CAR-T opportunities in 2026.
Read: justpaste.it/h5rud
@hemehub.bsky.social💭🎯 Today’s questions!
Swipe to see the answers and explanations!
#SmolderingMultipleMyeloma #SMM #MultipleMyeloma #Hematology #HemeOnc #Oncology #MedicalEducation #MedEd #ClinicalHematology #MRD #ASCT #StemCellTransplant #APOBEC #HemeHub
@onclive.bsky.socialWATCH 🎥: Zev A. Wainberg, MD, of @uclahealth.org, discusses the phase 3 DAWN-303 trial of INCB161734 plus chemotherapy and the expanding role of KRAS inhibitors in pancreatic cancer. #pancsm #oncology
Full video here ➡️: www.onclive.com/view/dr-wain...
@onclive.bsky.socialResponses to ADC TUB-040 did not differ by NaPi2b expression level in platinum-resistant ovarian cancer, supporting a biomarker-unrestricted development path, according to Toon Van Gorp, MD, PhD. @ascocancer.bsky.social #ASCO26 #gyncsm #oncology
More insights ➡️: www.onclive.com/view/napista...
@drtimos.bsky.social🚀 Get the #Oncology buzz from #ASCOGI25!
Top themes: #Efficacy 16.2%, #ClinicalTrials 16.1%, #Data 15.9%. #CRCsm & #GIOnc dominate, with #ctDNA & #Immunotherapy hot topics. 📊🩺
Download our full report! http://dlvr.it/TVZrrx
@ASCO
#SocialListening #LucidQuest
@juisci.bsky.socialTomorrow, 5:00 PM CEST. 🔴
New evidence, expert perspectives, clinical insights > first-line BRAF mCRC care, live with MD Anderson and Poitiers. Last chance to register (free, and you'll get the replay):
@4040rec.bsky.social
@fediboard-wellness.bsky.social